Quince Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Option Exercise | 30,000 | $2.23 | $66,900 | 30,000 | Jun 28, 2021 |
| Lynch Casey | Chief Executive Officer | Sale | 183 | $36.73 | $6,722 | 978,774 | May 10, 2021 |
| Lamond David | — | Purchase | 50,000 | $33.77 | $1,688,500 | 1,847,109 | Mar 24, 2021 |
| Lynch Casey | Chief Executive Officer | Sale | 18,089 | $35.85 | $648,491 | 1,009,474 | Mar 22, 2021 |
| Lamond David | — | Purchase | 4,100 | $36.86 | $151,126 | 1,797,109 | Mar 4, 2021 |
| Lamond David | — | Gift | 1,534,720 | — | — | 1,534,720 | Mar 4, 2021 |
| Lynch Casey | Chief Executive Officer | Sale | 100 | $38.28 | $3,828 | 1,079,145 | Feb 1, 2021 |
| Holsinger Leslie | Executive Vice President | Sale | 900 | $32.59 | $29,331 | 3,500 | Dec 14, 2020 |
| Holsinger Leslie | Executive Vice President | Option Exercise | 3,500 | $0.27 | $945 | 3,500 | Dec 10, 2020 |
| Boeding Chad | — | Purchase | 2,440 | $44.06 | $107,506 | 2,860,967 | Jun 11, 2020 |
| Lamond David | — | Purchase | 10,642 | $43.32 | $461,011 | 1,722,235 | Jun 4, 2020 |
| Pfizer Strategic Investment Holdings LLC | — | Sale | 370,000 | $40.18 | $14,866,600 | 2,879,973 | Jun 3, 2020 |
| Detke Michael J. | Chief Medical Officer | Option Exercise | 5,515 | $6.91 | $38,109 | 28,261 | May 27, 2020 |
| Boeding Chad | — | Purchase | 2,085 | $55.90 | $116,552 | 2,851,927 | May 20, 2020 |
| Lamond David | — | Purchase | 1,600 | $48.96 | $78,336 | 1,657,184 | May 15, 2020 |
| Detke Michael J. | Chief Medical Officer | Option Exercise | 5,515 | $6.91 | $38,109 | 22,746 | Apr 2, 2020 |
| Lamond David | — | Award / Grant | 30,000 | $50.00 | $1,500,000 | 1,653,336 | Feb 10, 2020 |
| Detke Michael J. | Chief Medical Officer | Option Exercise | 17,231 | $6.91 | $119,066 | 17,231 | Feb 7, 2020 |
| Boeding Chad | — | Other | 4,338 | $54.30 | $235,553 | 2,843,237 | Jan 29, 2020 |
| EPIQ Capital Group, LLC | — | Purchase | 420 | $24.87 | $10,445 | 2,845,940 | Aug 21, 2019 |
| EPIQ Capital Group, LLC | — | Purchase | 2,310 | $25.69 | $59,344 | 2,832,506 | Aug 20, 2019 |
| EPIQ Capital Group, LLC | — | Purchase | 2,100 | $26.50 | $55,650 | 2,842,610 | Aug 16, 2019 |
| Boeding Chad | — | Purchase | 2,100 | $26.50 | $55,650 | 2,829,596 | Aug 16, 2019 |
| Lamond David | — | C | 301,829 | — | — | 301,829 | May 13, 2019 |
| Lamond Christine | — | C | 961,510 | — | — | 961,510 | May 13, 2019 |
| TAKEDA PHARMACEUTICAL CO LTD | — | C | 2,679,802 | — | — | 2,679,802 | May 13, 2019 |
| Pfizer Ventures (US) LLC | — | C | 2,360,071 | — | — | 2,360,071 | May 13, 2019 |
| McLoughlin Margaret | — | Purchase | 550 | $17.00 | $9,350 | 550 | May 13, 2019 |
| RYAN UNA S | — | Purchase | 2,875 | $17.00 | $48,875 | 2,875 | May 13, 2019 |
| YOUNG KEVIN | — | Purchase | 30,000 | $17.00 | $510,000 | 30,000 | May 13, 2019 |
| Boeding Chad | — | Purchase | 80 | $27.05 | $2,164 | 2,839,810 | May 10, 2019 |
| EPIQ Capital Group, LLC | — | Purchase | 4,350 | $26.41 | $114,884 | 2,822,546 | May 10, 2019 |